View of Alteration of Panel-Reactive Antibodies Following Treatment With Either Atorvastatin or Low-Dose Mycophenolate Mofetil in Sensitized Hemodialysis Patients

Return to Article Details Alteration of Panel-Reactive Antibodies Following Treatment With Either Atorvastatin or Low-Dose Mycophenolate Mofetil in Sensitized Hemodialysis Patients Download Download PDF